Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshimitsu Fujii

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Intestinal Research|October 11, 2018
Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel diseaseShinichiro Shinzaki, Toshimitsu Fujii, Shigeki Bamba, et al.
Journal of Gastroenterology|August 5, 2022
Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD)Katsuyoshi Matsuoka, Toshimitsu Fujii, Ryuichi Okamoto, et al.
Journal of Crohn'S & Colitis|March 4, 2023
Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn's Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn's Disease (iCREST-CD)Takayuki Yamamoto, Hiroshi Nakase, Kenji Watanabe, et al.
Journal of Gastroenterology|January 30, 2025
First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control studyMakoto Naganuma, Hisashi Shiga, Masayuki Shimoda, et al.
Journal of Gastroenterology|January 29, 2020
A nationwide, multi-center, retrospective study of symptomatic small bowel stricture in patients with Crohn's diseaseShigeki Bamba, Ryosuke Sakemi, Toshimitsu Fujii, et al.
Journal of the Anus, Rectum and Colon|February 2, 2026
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2024 for the Clinical Practice of Inflammatory Bowel Disease-Associated Intestinal Neoplasia (English Version)Soichiro Ishihara, Shinji Tanaka, Toshio Uraoka, et al.
Journal of Gastroenterology|November 28, 2024
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation studyMakoto Okabe, Shuji Yamamoto, Masahiro Shiokawa, et al.
Inflammatory Bowel Diseases|January 27, 2021
Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel DiseaseKaoru Suzuki, Yoichi Kakuta, Takeo Naito, et al.
Journal of Gastroenterology|April 8, 2024
Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter studyMotoki Makuuchi, Yoichi Kakuta, Junji Umeno, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Intestinal Research|October 11, 2018
Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel diseaseShinichiro Shinzaki, Toshimitsu Fujii, Shigeki Bamba, et al.
Journal of Gastroenterology|August 5, 2022
Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD)Katsuyoshi Matsuoka, Toshimitsu Fujii, Ryuichi Okamoto, et al.
Journal of Crohn'S & Colitis|March 4, 2023
Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn's Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn's Disease (iCREST-CD)Takayuki Yamamoto, Hiroshi Nakase, Kenji Watanabe, et al.
Journal of Gastroenterology|January 30, 2025
First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control studyMakoto Naganuma, Hisashi Shiga, Masayuki Shimoda, et al.
Journal of Gastroenterology|January 29, 2020
A nationwide, multi-center, retrospective study of symptomatic small bowel stricture in patients with Crohn's diseaseShigeki Bamba, Ryosuke Sakemi, Toshimitsu Fujii, et al.
Journal of the Anus, Rectum and Colon|February 2, 2026
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2024 for the Clinical Practice of Inflammatory Bowel Disease-Associated Intestinal Neoplasia (English Version)Soichiro Ishihara, Shinji Tanaka, Toshio Uraoka, et al.
Journal of Gastroenterology|November 28, 2024
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation studyMakoto Okabe, Shuji Yamamoto, Masahiro Shiokawa, et al.
Inflammatory Bowel Diseases|January 27, 2021
Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel DiseaseKaoru Suzuki, Yoichi Kakuta, Takeo Naito, et al.
Journal of Gastroenterology|April 8, 2024
Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter studyMotoki Makuuchi, Yoichi Kakuta, Junji Umeno, et al.
Pageof 9